New self-expanding peripheral stent system launched by Invatec

Invatec, a comprehensive innovator of interventional products, today launched their latest self-expanding peripheral stent system, Maris Plus. The Maris Plus stent has a “lesion-specific” design with larger sizes to meet the clinical requirements of the iliac region. The Maris Plus becomes the sixth stent platform now marketed by Invatec for the treatment of Peripheral Arterial Disease (PAD), greatly optimizing visibility, flexibility and ease of use for the physician.

“At Invatec we pride ourselves on our ability to continually develop lesion specific solutions for Cardiovascular Arterial and Venous Disease. With the Maris Plus, we have created a novel, self-expanding stent platform specifically designed for the Iliac artery,” said Stefan Widensohler and Andrea Venturelli, co-founders of Invatec. The Maris Plus is available in a 30 – 100 mm length with 9.0 – 12.0 mm diameter, meeting the variable needs of the iliac region. The distinct stent geometry allows for increased stability in the hip, yet it remains the most flexible stent on the market. Additionally, larger and fully integrated tantalum markers greatly enhance visibility for the physician.

www.invatec.com 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New studies underscore the importance of inclusive approaches in peripheral artery disease treatment